Bristlecone Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.09M | Buy |
|
|||||
|
2024
Q4 | $866K | Hold |
|
|||||
|
2024
Q3 | $1,000K | Hold |
|
|||||
|
2024
Q2 | $1.01M | Sell |
|
|||||
|
2024
Q1 | $905K | Buy |
|
|||||
|
2023
Q4 | $834K | Buy |
|
|||||
|
2023
Q3 | $711K | Sell |
|
|||||
|
2023
Q2 | $739K | Sell |
|
|||||
|
2023
Q1 | $680K | Sell |
|
|||||
|
2022
Q4 | $718K | Sell |
|
|||||
|
2022
Q3 | $734K | Sell |
|
|||||
|
2022
Q2 | $723K | Buy |
|
|||||
|
2022
Q1 | $591K | Buy |
|
|||||
|
2021
Q4 | $492K | Buy |
|
|||||
|
2021
Q3 | $356K | Buy |
|
|||||
|
2021
Q2 | $314K | Buy |
|
|||||
|
2021
Q1 | $330K | Buy |
|
|||||
|
2020
Q4 | $322K | Buy |
|